JAGX stock: buy or sell?
June 26th, 2019
Jaguar Health, Inc., a commercial stage natural-products pharmaceuticals company, focuses on developing novel, sustainably derived gastrointestinal products for human prescription use and animals worldwide.
Should I buy JAGX stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. That's why is so important to choose your own trading plan that fits your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Jaguar Health stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Jaguar Health stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't detect any rating for JAGX stock for the last month.
JAGX stock analysis
After boosting an amazing 8.06% yesterday, Jaguar Health closed today at $4.84 and fell a rough -2.42%.
After boosting an amazing 8.06% yesterday, Jaguar Health closed today at $4.84 and fell a rough -2.42%. Since price and SMA100d lines crossed down on April, JAGX fell $-14.76 per share (-75.31%).
After sliding a frightening -32.20% in a week last week, Jaguar Health closed this week at $4.84 and jumped a shining 3.20%. By mid May JAGX boosted a dazzling 15.49% in just one week. This week broke a red streak of 4 weeks.
Since price and 20-weeks moving average lines crossed down early April, JAGX fell $-17.28 per share (-78.12%).
JAGX stock price history
JAGX IPO was on June 9th, 2016 at $2,940.00 per share1. Since then, JAGX stock sliced a -99.80%, with a yearly average of -33.30%.
1: Adjusted price after possible price splits or reverse-splits.
JAGX stock historical price chart
JAGX stock reached 52-week highs at $224.00, and all-time highs 2016-06-09 with a price of 3979.5.
JAGX stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' JAGX stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not detected any price prediction for Jaguar Health stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter publishing its last earnings report on April, Jaguar Health plummed a scary -77.70%. As soon as we get its actual EPS from the earnings report, we will update this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual turnover report draw a slightly fine growth of 1.26% to $4.42 M dollars. When comparing 2018 vs 2017, nonetheless, profit margin (that is, the net income divided by revenues) plummed a -224.19% to -727.92%.
|2015||$0.26 M||-||$-16.29 M-6305.2%||-|
|2016||$0.14 M||-45.23%||$-14.73 M-10410.9%||-9.56%|
|2017||$4.36 M||2,981.61%||$-21.97 M-503.7%||49.10%|
|2018||$4.42 M||1.26%||$-32.15 M-727.9%||46.33%|
Quarterly financial resultsJaguar Health reported $1.60 million in revenues for 2018-Q4, a 40.97% improvement compared to previous quarter. Reported quarter income marked $-12.65 M with a profit margin of -792.91%. Profit margin plunged a -250.69% compared to previous quarter when profit margin was -542.22%. When comparing turnover to same quarter last year, Jaguar Health sales marked a decent gain and appreciated a 3.49%. Looking back to recent quarterly results, Jaguar Health posted 3 positive quarters in a row.
|2017-Q1||$0.82 M||-||$-4.72 M-573.9%||-|
|2017-Q2||$0.90 M||9.01%||$-1.81 M-201.9%||-61.65%|
|2017-Q3||$1.10 M||22.72%||$4.76 M432.6%||-362.97%|
|2017-Q4||$1.54 M||40.16%||$-20.21 M-1310.4%||-524.54%|
|2018-Q1||$0.80 M||-47.84%||$-5.70 M-708.2%||-71.81%|
|2018-Q2||$0.88 M||9.88%||$-7.66 M-866.3%||34.42%|
|2018-Q3||$1.13 M||28.08%||$-6.14 M-542.2%||-19.84%|
|2018-Q4||$1.60 M||40.97%||$-12.65 M-792.9%||106.14%|
Jaguar Health ownershipWhen you are planning to invest in a stock, it's always worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Jaguar Health, 13.23% of all outstanding shares are owned by its staff.
In case of Jaguar Health stock, 13.20% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for JAGX stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related companies:
|Market cap||$4.9 M|
|Total shares||1.0 M|
|Float shares||1.0 M|
|- Institutional holdings (%)||13.2%|
|- Insider holdings (%)||13.2%|
|Shares in short selling||0.0%|
|Wednesday, June 26th, 2019|
|Day range||$4.68 - $5.01|
|Average true range||$1.64|
|50d mov avg||$11.66|
|100d mov avg||$14.38|
|200d mov avg||$22.94|
Jaguar Health performanceTo better understand Jaguar Health performance you must becnhmark its gains with other related stocks in same sector or industry. In the following table, we compare Jaguar Health performance to :